ebomi
Colour theme
Sign in
Insider · CIK 0001704268

Mubadala Investment Co PJSC

CIK 0001704268 Name as filed on the most recent filing

Filed as Mubadala Investment Co PJSC (24)

34 transaction lines · from 24 filings · filed 2017-08-04 to 2025-09-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

3 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-07-29 P, Open-market purchase MidCap Apollo Institutional Private LendingNONE 18,683,604, acquired Open Form 4 filing 0000950170-25-101063
2024-06-14 P, Open-market purchase MidCap Apollo Institutional Private LendingNONE 43,261,453, acquired Open Form 4 filing 0000950170-25-114223
2023-03-02 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 522,354, acquired Open Form 4 filing 0001839882-23-005947
2023-03-01 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 388,082, acquired Open Form 4 filing 0001387131-23-002722
2023-02-28 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 6,496, acquired Open Form 4 filing 0001387131-23-002678
2023-02-27 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 403,725, acquired Open Form 4 filing 0001387131-23-002560
2023-02-24 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 833,552, acquired Open Form 4 filing 0001839882-23-004972
2023-02-23 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 403,792, acquired Open Form 4 filing 0001387131-23-002375
2023-02-22 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 399,016, acquired Open Form 4 filing 0001387131-23-002324
2023-02-21 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 731,126, acquired Open Form 4 filing 0001387131-23-002285
2023-02-17 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 488,986, acquired Open Form 4 filing 0001387131-23-002254
2023-02-16 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 337,043, acquired Open Form 4 filing 0001387131-23-002226
2023-02-14 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 50,060, acquired Open Form 4 filing 0001839882-23-003873
2023-02-13 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 258,837, acquired Open Form 4 filing 0001839882-23-003743
2023-02-10 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 87,808, acquired Open Form 4 filing 0001387131-23-001898
2023-02-01 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 4,782, acquired Open Form 4 filing 0001839882-23-002830
2023-01-26 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 63,006, acquired Open Form 4 filing 0001387131-23-000851
2023-01-25 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 193,267, acquired Open Form 4 filing 0001839882-23-001552
2023-01-10 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 536,846, acquired Open Form 4 filing 0001387131-23-000335
2023-01-09 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 580,839, acquired Open Form 4 filing 0001387131-23-000335
2023-01-06 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 510,611, acquired Open Form 4 filing 0001387131-23-000335
2023-01-05 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 590,554, acquired Open Form 4 filing 0001387131-23-000335
2023-01-04 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 716,877, acquired Open Form 4 filing 0001387131-23-000335
2023-01-03 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 1,063,011, acquired Open Form 4 filing 0001387131-23-000335
2022-12-30 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 753,622, acquired Open Form 4 filing 0001387131-23-000335
2022-12-29 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 652,774, acquired Open Form 4 filing 0001387131-23-000335
2022-12-28 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 511,898, acquired Open Form 4 filing 0001387131-23-000335
2022-12-27 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 1,054,404, acquired Open Form 4 filing 0001387131-23-000335
2022-12-23 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 754,421, acquired Open Form 4 filing 0001387131-23-000335
2021-04-16 P, Open-market purchase Recursion Pharmaceuticals, Inc.RXRX 49,999,986, acquired Open Form 4 filing 0001387131-21-004685
2019-02-05 S, Open-market sale Advanced Micro Devices IncAMD 817,851,469, disposed Open Form 4 filing 0000947871-19-000080
2018-12-04 P, Open-market purchase Gaia, IncGAIA 194,285, acquired Open Form 4 filing 0000947871-19-000369
2018-07-30 S, Open-market sale Advanced Micro Devices IncAMD 425,150,000, disposed Open Form 4 filing 0000947871-18-000617
2017-08-04 S, Open-market sale Advanced Micro Devices IncAMD 21,024,000,000,000,000, disposed Open Form 4 filing 0000947871-17-000614

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 3
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mubadala Investment Co PJSC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001704268

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.